Taste bud maintenance in mice requires Hedgehog signaling

November 28, 2016

Disruptions in the Hedgehog signaling pathway can interfere with taste bud maintenance in mice, potentially explaining why some cancer patients experience a loss of taste during treatment with Hedgehog-blocking drugs. Charlotte Mistretta and Andrzej Dlugosz of the University of Michigan in Ann Arbor, with colleagues, report these findings November 28th in PLOS Genetics.

To keep one's sense of taste, the taste buds and specialized mounds of tissue they reside in, called taste papillae, must be constantly renewed, with taste bud cells lasting an average of just 10 days. Scientists investigated the role of the Hedgehog signaling pathway, an important regulator of development and cell differentiation, in maintaining the dynamic taste buds and papillae. They used a panel of mouse models that enabled them to block, in some cases reversibly, regulatory GLI proteins that are responsible for Hedgehog-driven changes in gene expression. When the Hedgehog pathway was inhibited, taste buds rapidly disappeared and papillae lost their characteristic shape, even though the taste nerves were still present. Once Hedgehog signaling resumed, a significant fraction of the taste buds regenerated.

The study may help explain a common side effect in cancer patients treated with drugs that block the Hedgehog pathway. These individuals often report a loss of taste which gradually returns after treatment is stopped. Preventing the disappearance of taste buds during Hedgehog pathway blockade might reduce the taste loss experienced by these patients. These results raise the possibility that other conditions associated with a taste disturbance may also be explained by changes in the Hedgehog pathway.

Andrzej Dlugosz and Charlotte Mistretta say "We're pretty excited about these results because they provide the first genetic evidence that Hedgehog signaling is essential for taste bud maintenance in adult animals. Also, with the types of mouse models we used, we can now say that the critical site for Hedgehog signaling in taste organ maintenance is within epithelial cells of the taste papillae, where taste buds reside. If our results in mice reflect what happens in cancer patients who lose their taste when taking Hedgehog pathway inhibitors, it might be possible to get around this side effect if we can find a way to protect taste buds from the effects of the drug. Further, because the sense of taste is so central in our everyday lives for food choices and pleasurable aspects of eating, understanding how taste organ homeostasis is regulated significantly advances our understanding of sensory biology."
-end-
In your coverage please use this URL to provide access to the freely available article in PLOS Genetics: http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1006442

Citation: Ermilov AN, Kumari A, Li L, Joiner AM, Grachtchouk MA, Allen BL, et al. (2016) Maintenance of Taste Organs Is Strictly Dependent on Epithelial Hedgehog/GLI Signaling. PLoS Genet 12(11): e1006442. doi:10.1371/journal.pgen.1006442

Funding: This work was supported by NIH National Institute on Deafness and Other Communication Disorders (NIDCD) NIH NIDCD Multi PI R01 DC0114428 to BLA, AAD, CMM; NIH National Institute on Deafness and Other Communication Disorders (NIDCD) NIH NIDCD DC00456 to CMM; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH R01 AR045973 to AAD; NIH National Cancer Institute (NCI) NIH P30 CA046592 to AAD; NIH National Cancer Institute (NCI) NIH R01 CA198074 to BLA; NIH National Institute on Deafness and Other Communication Disorders (NIDCD) NIH F31 DC013496 to AMJ; University of Michigan Center for Organogenesis Postdoctoral Fellowship to AK; (University of Michigan Center for Organogenesis Research Team Award to BLA, AAD, CMM; University of Michigan M-Cubed Program Team Awards to BLA, AAD, CMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.

PLOS

Related Cancer Patients Articles from Brightsurf:

Higher risk of death in cancer patients with COVID-19 may be due to advanced age and more pre-existing conditions, rather than cancer itself
New research presented at this this week's ESCMID Conference on Coronavirus Diseases (ECCVID, online 23-25 September) suggests that the poor outcomes and higher death rates in cancer patients with COVID-19 could be due to them generally being older and having more underlying conditions, rather than due to the cancer itself.

The Lancet: Prostate cancer study finds molecular imaging could transform management of patients with aggressive cancer
Results from a randomised controlled trial involving 300 prostate cancer patients find that a molecular imaging technique is more accurate than conventional medical imaging and recommends the scans be introduced into routine clinical practice.

The art of cancer caregiving: How art therapies benefits those caring for cancer patients
A recent Drexel University study showed coloring and open-studio art therapy benefits stressed caregivers of cancer patients.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer tissue-freezing approach may help more breast cancer patients in lower income countries
A new reusable device created by the Johns Hopkins University can help women with breast cancer in lower income countries by using carbon dioxide, a widely available and affordable gas, to power a cancer tissue-freezing probe instead of industry-standard argon.

Lots of patients with cancer, cancer survivors use but don't report complementary/alternative medicine therapies
This study used data from a nationwide survey to estimate how many patients with cancer and cancer survivors use complementary and alternative medicines (CAMS) in addition to or instead of conventional therapies, and how many don't disclose that to their physicians.

Colorectal cancer in patients with early onset is distinct from that in older patients
New research indicates that colorectal cancer diagnosed at an early age has clinical and genetic features that are different from those seen in traditional colorectal cancer diagnosed later in life.

Comparable risk of recurrent venous thromboembolism between patients with unprovoked venous thromboembolism and patients with cancer
Patients with venous thromboembolism (VTE) carry a high risk of recurrence.

Personalized cancer vaccine may increase long-term survival in patients with deadly brain cancer
An international Phase III study led by researchers at UCLA has found that a personalized GBM vaccine may increase long-term survival in some patients.

Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation
A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options.

Read More: Cancer Patients News and Cancer Patients Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.